Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xolair in allergen bronchoprovocation in asthma
NCT00624832Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2008
- Primary completion
- Jan 2009
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 4 trial of omalizumab in asthma, sponsored by Novartis. Started Feb 2008; status: completed.
02
Drugs
omalizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00624832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624832.